In conclusion, in premenopausal women diagnosed with low-risk endometrial cancer and elevated CA125 levels, the likelihood of LN metastasis or recurrence is minimal and the overall prognosis is favorable. This evidence concerns the gene MUC16 and endometrial cancer.